The Liver in Heart Failure: From Biomarkers to Clinical Risk.

Abstract

Heart failure (HF) is a clinical syndrome due to heart dysfunction, but in which other organs are also involved, resulting in a complex multisystemic disease, burdened with high mortality and morbidity. This article focuses on the mutual relationship between the heart and liver in HF patients. Any cause of right heart failure can cause hepatic congestion, with important prognostic significance. We have analyzed the pathophysiology underlying this double interaction. Moreover, we have explored several biomarkers and non-invasive tests (i.e., liver stiffness measurement, LSM) potentially able to provide important support in the management of this complex disease. Cardiac biomarkers have been studied extensively in cardiology as a non-invasive diagnostic and monitoring tool for HF. However, their usefulness in assessing liver congestion in HF patients is still being researched. On the other hand, several prognostic scores based on liver biomarkers in patients with HF have been proposed in recent years, recognizing the important burden that liver involvement has in HF. We also discuss the usefulness of a liver stiffness measurement (LSM), which has been recently proposed as a reliable and non-invasive method for assessing liver congestion in HF patients, with therapeutic and prognostic intentions. Lastly, the relationship between LSM and biomarkers of liver congestion is not clearly defined; more research is necessary to establish the clinical value of biomarkers in assessing liver congestion in HF patients and their relationship with LSM.

• Authors: Nadia Aspromonte, Isabella Fumarulo, Lucrezia Petrucci, Bianca Biferali, Antonio Liguori, Antonio Gasbarrini, Massimo Massetti, Luca Miele
• Journal: International journal of molecular sciences (Int J Mol Sci) Vol. 24 Issue 21 (Oct 27 2023) ISSN: 1422-0067 [Electronic] Switzerland
• PMID: 37958649 (Publication Type: Journal Article, Review)

Chemical References

• Biomarkers

Topics

• Humans
• Liver (pathology)
• Liver Diseases (pathology)
• Heart Failure (diagnosis, pathology)
• Biomarkers
• Elasticity Imaging Techniques (methods)
• Liver Cirrhosis (pathology)